• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

局部缺血后外科再灌注与药物再灌注的优越性。

Superiority of surgical versus medical reperfusion after regional ischemia.

作者信息

Vinten-Johansen J, Buckberg G D, Okamoto F, Rosenkranz E R, Bugyi H, Leaf J

出版信息

J Thorac Cardiovasc Surg. 1986 Sep;92(3 Pt 2):525-34.

PMID:3747580
Abstract

This study tests the hypothesis that surgical revascularization (i.e., simulating coronary artery bypass grafting) with control of reperfusion conditions (total vented bypass) and of reperfusate composition (substrate-enriched blood cardioplegic solution) produces better recovery than is possible in the non-surgical setting (i.e., normal blood in beating, working hearts to simulate streptokinase and angioplasty). Eighteen dogs underwent 2 hours of left anterior descending coronary artery ligation (35% of the left ventricle at risk) followed by 2 hours of reperfusion. In five dogs the ligature was released to simulate streptokinase thrombolysis and angioplasty in working hearts (medical). In 13 dogs, surgical reperfusion was accomplished during total vented bypass, where six dogs received normal blood and seven others received substrate-enriched blood cardioplegic solution with 1 additional hour of aortic clamping (i.e., a total of 3 hours of ischemia). Segmental shortening with ultrasonic crystals, tissue water content, and vital staining (triphenyltetrazolium chloride) were assessed. Ischemia produced severe systolic bulging (-42% of control systolic shortening, p less than 0.05). Medical reperfusion resulted in failure to restore regional contractility (-27% systolic shortening, p less than 0.05), severe edema (82.4% H2O content, p less than 0.05), and extensive transmural nonstaining (44%, p less than 0.05). In contrast, surgical reperfusion with substrate-enriched blood cardioplegic solution during total vented bypass restored regional contraction to 46% of control values (p less than 0.05) and resulted in less edema (80.6% H2O content, p less than 0.05), and only mild nonstaining (21%, p less than 0.05) restricted to the subendocardial region. Surgical revascularization with controlled reperfusion conditions and reperfusate composition produces better myocardial salvage than is possible in the medical setting, despite a longer period of ischemia.

摘要

本研究检验了以下假设

通过控制再灌注条件(全排气旁路)和再灌注液成分(富含底物的血液停搏液)进行手术血运重建(即模拟冠状动脉搭桥术),比在非手术环境下(即跳动、工作的心脏中的正常血液以模拟链激酶和血管成形术)能产生更好的恢复效果。18只狗接受了2小时的左前降支冠状动脉结扎(左心室35%处于危险中),随后进行2小时的再灌注。5只狗松开结扎线以模拟工作心脏中的链激酶溶栓和血管成形术(药物治疗组)。13只狗在全排气旁路期间进行手术再灌注,其中6只狗接受正常血液,另外7只狗接受富含底物的血液停搏液,并额外进行1小时的主动脉钳夹(即总共3小时的缺血)。使用超声晶体评估节段缩短、组织含水量和活体染色(氯化三苯基四氮唑)。缺血导致严重的收缩期膨出(对照收缩期缩短的-42%,p<0.05)。药物再灌注未能恢复局部收缩力(收缩期缩短-27%,p<0.05),出现严重水肿(含水量82.4%,p<0.05),以及广泛的透壁无染色(44%,p<0.05)。相比之下,在全排气旁路期间使用富含底物的血液停搏液进行手术再灌注,使局部收缩恢复到对照值的46%(p<0.05),水肿较轻(含水量80.6%,p<0.05),仅心内膜下区域有轻度无染色(21%,p<0.05)。尽管缺血时间更长,但通过控制再灌注条件和再灌注液成分进行手术血运重建比药物治疗能产生更好的心肌挽救效果。

相似文献

1
Superiority of surgical versus medical reperfusion after regional ischemia.局部缺血后外科再灌注与药物再灌注的优越性。
J Thorac Cardiovasc Surg. 1986 Sep;92(3 Pt 2):525-34.
2
Immediate functional recovery after six hours of regional ischemia by careful control of conditions of reperfusion and composition of reperfusate.
J Thorac Cardiovasc Surg. 1986 Sep;92(3 Pt 2):621-35.
3
Regional blood cardioplegic reperfusion during total vented bypass without thoracotomy: a new concept.非开胸全腔静脉转流期间的区域性血液心脏停搏再灌注:一个新概念。
J Thorac Cardiovasc Surg. 1986 Sep;92(3 Pt 2):553-63.
4
Studies of controlled reperfusion after ischemia. XIX. Reperfusate composition: benefits of blood cardioplegia over fluosol DA cardioplegia during regional reperfusion--importance of including blood components in the initial reperfusate.缺血后控制性再灌注的研究。第十九部分。再灌注液成分:在局部再灌注期间血液停搏液优于氟碳化合物DA停搏液的益处——初始再灌注液中包含血液成分的重要性。
J Thorac Cardiovasc Surg. 1991 Feb;101(2):284-93.
5
Reperfusion conditions: critical importance of total ventricular decompression during regional reperfusion.再灌注条件:局部再灌注期间全心室减压的至关重要性。
J Thorac Cardiovasc Surg. 1986 Sep;92(3 Pt 2):605-12.
6
Reperfusate composition: supplemental role of intravenous and intracoronary coenzyme Q10 in avoiding reperfusion damage.再灌注液成分:静脉内和冠状动脉内辅酶Q10在避免再灌注损伤中的补充作用。
J Thorac Cardiovasc Surg. 1986 Sep;92(3 Pt 2):573-82.
7
Studies of controlled reperfusion after ischemia. XXIII. Deleterious effects of simulated thrombolysis preceding simulated coronary artery bypass grafting with controlled blood cardioplegic reperfusion.缺血后控制性再灌注的研究。XXIII. 在控制性血液停搏液再灌注的模拟冠状动脉旁路移植术前进行模拟溶栓的有害影响。
J Thorac Cardiovasc Surg. 1991 Mar;101(3):455-64.
8
Studies on prolonged acute regional ischemia. IV. Aggressive surgical treatment for intractable ventricular fibrillation after acute myocardial infarction.急性局部缺血延长的研究。IV. 急性心肌梗死后顽固性心室颤动的积极手术治疗。
J Thorac Cardiovasc Surg. 1989 Oct;98(4):557-66.
9
Effects of "duration" of reperfusate administration versus reperfusate "dose" on regional functional, biochemical, and histochemical recovery.
J Thorac Cardiovasc Surg. 1986 Sep;92(3 Pt 2):594-604.
10
Studies of controlled reperfusion after ischemia. XVIII. Reperfusion conditions: attenuation of the regional ischemic effect by temporary total vented bypass before controlled reperfusion.缺血后控制性再灌注的研究。十八、再灌注条件:控制性再灌注前通过临时全流量体外循环减轻局部缺血效应
J Thorac Cardiovasc Surg. 1990 Nov;100(5):737-44.

引用本文的文献

1
High-intensity interval training improves mitochondrial function and attenuates cardiomyocytes damage in ischemia-reperfusion.高强度间歇训练可改善线粒体功能并减轻缺血再灌注中的心肌细胞损伤。
Int J Cardiol Heart Vasc. 2025 Jul 25;60:101756. doi: 10.1016/j.ijcha.2025.101756. eCollection 2025 Oct.
2
Controlling Reperfusion Injury With Controlled Reperfusion: Historical Perspectives and New Paradigms.控制性再灌注防治再灌注损伤:历史观点与新范例。
J Cardiovasc Pharmacol Ther. 2021 Nov;26(6):504-523. doi: 10.1177/10742484211046674. Epub 2021 Sep 17.
3
The paradigm of postconditioning to protect the heart.
用于保护心脏的后适应范式。
J Cell Mol Med. 2008 Apr;12(2):435-58. doi: 10.1111/j.1582-4934.2007.00210.x. Epub 2007 Dec 20.
4
Cyclic GMP and protein kinase-G in myocardial ischaemia-reperfusion: opportunities and obstacles for survival signaling.心肌缺血再灌注中的环磷酸鸟苷与蛋白激酶 G:生存信号传导的机遇与障碍
Br J Pharmacol. 2007 Nov;152(6):855-69. doi: 10.1038/sj.bjp.0707409. Epub 2007 Aug 13.
5
Myocardial protection during surgical intervention for treatment of acute myocardial infarction.急性心肌梗死手术治疗期间的心肌保护
Tex Heart Inst J. 1992;19(1):26-40.